Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
TC BioPharm
company
About
TC BioPharm develops safer, cheaper, consistent, and durable CAR-T drugs for hematological and solid tumors.
- 51 - 100
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $16M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2013
- Number Of Employee
- 51 - 100
- Operating Status
- Active
TC BioPharm develops safer, cheaper, consistent, and durable CAR-T drugs for hematological and solid tumors. TC BioPharm’s mission is to develop and commercialize innovative cell-based products to treat disease, improving patient health and quality of life.
TC BioPharm is a clinical development company with a cell-based product pipeline capable of treating a variety of disorders, including cancer and severe viral infections. TCB is currently conducting Phase II/III clinical studies of its lead product, ImmuniCell, in renal cell cancinoma, non-small cell lung cancer and melanoma patients.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$16M
TC BioPharm has raised a total of
$16M
in funding over 2 rounds. Their latest funding was raised on
Dec 7, 2017 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 7, 2017 | Series B | $16M | 1 |
Bluebird Bio
|
— | Detail |
Investments
Number of Investments
Number of Lead Investments
1
0
TC BioPharm has made 1 investments. Their most recent investment was on
Dec 15, 2021, when Forethought raised $65M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Dec 15, 2021
Forethought
|
Series C | $65M | Artificial Intelligence | — |
Investors
Number of Lead Investors
Number of Investors
1
1
TC BioPharm is funded by 1 investors.
Bluebird Bio
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Bluebird Bio
|
Yes | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
